New York, NY
Shockwave Therapy clinics in New York
New York has multiple clinics advertising shockwave therapy, spanning orthopedic, podiatric, men's health, and aesthetic applications. New York has a concentrated shockwave market across Manhattan and outer boroughs, with heavy urology and men's health positioning. New York providers typically run focused shockwave for FDA cleared orthopedic indications like plantar fasciitis, lateral epicondylitis tennis elbow, and chronic tendinopathy, and radial or low intensity shockwave (LI-ESWT, often branded as GAINSWave) off label for erectile dysfunction in 6 session protocols. Kidney stone lithotripsy is a separate FDA cleared category usually performed in hospital settings. Local pricing in New York sits in the premium range, with a standard 6 session ED protocol commonly quoted at 3,000 to 7,500 dollars, while single session orthopedic shockwave runs 250 to 500. Device matters: verify the clinic uses an FDA cleared unit like Storz, Chattanooga, or BTL rather than a low end imported device. Evidence for orthopedic shockwave is Strong for plantar fasciitis and tennis elbow, while LI-ESWT for ED remains Emerging, with several randomized trials showing benefit but inconsistent protocols. A reputable New York clinic frames this evidence honestly and matches provider specialty to the indication.
Stem Regen Medical
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- Shockwave Therapy
- Ozone Therapy
Michael Rotman, MD
- PRP Therapy
- Shockwave Therapy
- Arthritis Treatment
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
KNOSIS Physical Therapy
- Biofeedback Therapy
- Shockwave Therapy
- Arthritis Treatment
- Red Light Therapy
- TMJ Treatment
Gotham Footcare and Podiatry - Downtown
- PRP Therapy
- Shockwave Therapy
- Hyperbaric Oxygen Therapy (HBOT)
- Arthritis Treatment
- Cryotherapy
Regenerative Sportscare Institute
- PRP Therapy
- Shockwave Therapy
- Arthritis Treatment
- Stem Cell Therapy
BeRejuved Medical Spa & Wellness Studio - NYC
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- Shockwave Therapy
- IV Therapy
Yoo Balance Therapy & Wellness
- PRP Therapy
- Shockwave Therapy
- Arthritis Treatment
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
Integrative Spine & Sports
- PRP Therapy
- Shockwave Therapy
- IV Hydration
- Arthritis Treatment
- Stem Cell Therapy
Body Harmony Physical Therapy
- Shockwave Therapy
- Erectile Dysfunction (ED) Treatment
- TMJ Treatment
Regulatory context
A note on New York's shockwave therapy rules.
FDA 510(k) clearances exist for specific extracorporeal shockwave devices indicated for chronic plantar fasciitis and lateral epicondylitis. Shockwave lithotripsy for kidney stones is approved under 21 CFR 876. LI-ESWT is not FDA-approved for erectile dysfunction in the United States as of 2026, and no shockwave device is FDA-cleared for knee osteoarthritis, Peyronie's disease, cellulite, or sexual wellness indications. Off-label use by licensed practitioners is permitted, but marketing implying FDA approval for those uses is not and is subject to FDA, FTC, and state enforcement.
-
New York Education Law Title VIII, Article 131
Governs medical licensure in New York. -
New York Education Law Title VIII, Article 132
Governs chiropractic licensure and scope. -
New York General Business Law 349
Prohibits deceptive acts and practices, applied to health advertising.
The New York State Education Department's Office of the Professions oversees medical, chiropractic, and physical therapy licensure, while the Office of Professional Medical Conduct (OPMC) investigates physicians. The New York Attorney General applies GBL 349 aggressively to deceptive health advertising and has a history of pursuing regenerative medicine and men's health clinics for unsupported claims. New York City and Long Island have been particular enforcement hotspots. Shockwave clinics advertising ED treatment as FDA-approved face elevated exposure. Regenerated.com listings in New York should reflect accurate FDA-clearance status and avoid approval language for off-label uses.